Pointcross Life Sciences
Private Company
Funding information not available
Overview
PointCross Life Sciences is a private, revenue-generating software and services company founded in 2016, focusing on the high-compliance niche of clinical and nonclinical data orchestration for regulatory submissions. Its flagship XBIOM™ platform automates data transformation, validation, and reporting, integrating AI via secure, firewall-deployed LLMs to enable natural language querying of study data. The company claims significant efficiency gains, including reducing SEND and study report generation to 2-3 weeks, and serves biopharma sponsors and CROs by addressing critical bottlenecks in the drug development pathway.
Technology Platform
XBIOM™ Clinical Data Automation Platform (CDAP) - an integrated suite for clinical/nonclinical data ingestion, curation, transformation (to SEND/SDTM/ADaM), validation, warehousing, and AI-powered analytics. Features secure, firewall-deployed LLMs for Retrieval-Augmented Generation (RAG) enabling natural language querying of study data.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes with large clinical trial technology providers (e.g., Veeva Vault Clinical, Medidata), specialized SEND service vendors, and legacy clinical data management system providers. Differentiation is based on the integrated 'Single Track' automation for nonclinical studies, the secure AI/LLM capability, and a platform that spans both clinical and nonclinical data.